Literature DB >> 24450560

Using two different algorithms to determine the prevalence of sarcopenia.

Daisuke Yoshida1, Takao Suzuki, Hiroyuki Shimada, Hyuntae Park, Hyuma Makizako, Takehiko Doi, Yuya Anan, Kota Tsutsumimoto, Kazuki Uemura, Tadashi Ito, Sangyoon Lee.   

Abstract

AIM: Several operative definitions and screening methods for sarcopenia have been proposed in previous studies; however, the opinions of researchers still differ. We compared the prevalence of sarcopenia using two different algorithms: (i) the European working group on sarcopenia in older people (EWGSOP)-suggested algorithm using gait speed as the first step; and (ii) the muscle mass and strength algorithm.
METHODS: A population-based, cross-sectional survey of adults aged over 65 years was carried out. Data on a total of 4811 participants were available for analysis. Gait speed, grip strength and appendicular skeletal muscle mass were assessed to determine sarcopenia. Appendicular skeletal muscle mass was estimated from bioimpedance analysis measurements and expressed as skeletal muscle mass index. Grip strength and skeletal muscle mass index were considered to be low if they fell below the threshold of the lowest 20% of values measured in a subset of healthy subjects. We compared the prevalence rates of sarcopenia determined by the two algorithms.
RESULTS: The prevalence rate of sarcopenia in a representative sample of older Japanese adults was 8.2% for men and 6.8% for women based on the EWGSOP algorithm. The two algorithms identified the same participants as sarcopenic, the only difference being the EWGSOP algorithm classified an additional seven participants (0.15%) into sarcopenia compared with the muscle mass and strength algorithm.
CONCLUSION: It is debatable whether inclusion of gait speed is necessary when screening for sarcopenia in community-dwelling older adults. Future research should examine the necessity of including gait speed in algorithms and the validity of cut-off values.
© 2014 Japan Geriatrics Society.

Entities:  

Keywords:  aging; prevalence; sarcopenia

Mesh:

Year:  2014        PMID: 24450560     DOI: 10.1111/ggi.12210

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  48 in total

Review 1.  Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: A systematic review and meta-analysis.

Authors:  Hyuma Makizako; Yuki Nakai; Kazutoshi Tomioka; Yoshiaki Taniguchi
Journal:  Phys Ther Res       Date:  2019-11-29

2.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  The association of back muscle strength and sarcopenia-related parameters in the patients with spinal disorders.

Authors:  Hiromitsu Toyoda; Masatoshi Hoshino; Shoichiro Ohyama; Hidetomi Terai; Akinobu Suzuki; Kentaro Yamada; Shinji Takahashi; Kazunori Hayashi; Koji Tamai; Yusuke Hori; Hiroaki Nakamura
Journal:  Eur Spine J       Date:  2018-12-12       Impact factor: 3.134

4.  Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy.

Authors:  Yasunari Fukuda; Kazuyoshi Yamamoto; Motohiro Hirao; Kazuhiro Nishikawa; Yukiko Nagatsuma; Tamaki Nakayama; Sugano Tanikawa; Sakae Maeda; Mamoru Uemura; Masakazu Miyake; Naoki Hama; Atsushi Miyamoto; Masataka Ikeda; Shoji Nakamori; Mitsugu Sekimoto; Kazumasa Fujitani; Toshimasa Tsujinaka
Journal:  Gastric Cancer       Date:  2015-09-25       Impact factor: 7.370

5.  Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: the Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus.

Authors:  A I Rodriguez-Rejon; R Artacho; A Puerta; A Zuñiga; M D Ruiz-Lopez
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

6.  Screening for Malnutrition in Community Dwelling Older Japanese: Preliminary Development and Evaluation of the Japanese Nutritional Risk Screening Tool (NRST).

Authors:  N C Htun; K Ishikawa-Takata; A Kuroda; T Tanaka; T Kikutani; S P Obuchi; H Hirano; K Iijima
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

7.  Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis.

Authors:  S K Papadopoulou; P Tsintavis; P Potsaki; D Papandreou
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

8.  Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.

Authors:  Ryusuke Shodo; Keisuke Yamazaki; Yushi Ueki; Takeshi Takahashi; Arata Horii
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-08       Impact factor: 2.503

9.  Feasibility of computed tomography-based assessment of skeletal muscle mass in hemodialysis patients.

Authors:  Tomoaki Takata; Aki Motoe; Katsumi Tanida; Sosuke Taniguchi; Ayami Ida; Kentaro Yamada; Shintaro Hamada; Masaya Ogawa; Marie Yamamoto; Yukari Mae; Takuji Iyama; Munehiro Taniguchi; Akihisa Nakaoka; Hajime Isomoto
Journal:  J Nephrol       Date:  2020-09-29       Impact factor: 3.902

10.  Association between Geriatric Nutrition Risk Index and low muscle mass in Chinese elderly people.

Authors:  Yujie Zhang; Shihui Fu; Jingxin Wang; Xin Zhao; Qiang Zeng; Xiaoying Li
Journal:  Eur J Clin Nutr       Date:  2018-10-04       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.